CGRP antagonists

Artikelen filtered by tag "CGRP antagonists"

The following articles contain the tag CGRP antagonists:

New drug: lasmiditan for migraine attacks

Two new drugs for the acute treatment of migraine attacks were authorised in 2022. They concern the ‘calcitonin gene-related peptide’ (CGRP) antagonist rimegepant, which was previously discussed in Ge-Bu, and the 5HT1F agonist lasmiditan. New age ...

In short Read article

New drug: rimegepant for migraine attacks

Two million people in the Netherlands regularly experience migraine. In addition to preventive medication, a large proportion of patients also use drugs for the acute treatment of a migraine attack. The cornerstone of this therapy are the triptan ...

In short Read article

New drugs for migraine prophylaxis

The discovery of the role of ‘calcitonin gene-related peptide’ (CGRP) in the development of migraine enabled new drugs for the treatment of this condition to be developed. The monoclonal CGRP antagonists erenumab, fremanezumab and galcanezumab ha ...

In short Read article